HEDIS® Results
Medicaid HEDIS® Annual Rates.
Molina’s scores for the past two years are below. You can see how Molina performs compared to the NCQA 66.67th percentile Quality Compass Benchmark.
The HEDIS reporting year is the year after the data was collected. For example, “2024 Rate” includes data from January to December 2023 and “2025 Rate” includes data from January to December 2024.
|
Measure |
2024 Rate |
2025 Rate |
Goal |
|
Effectiveness of Care: Prevention and Screening |
|||
|
Adult Immunization Status (AIS-E) - Influenza (Total) |
15.99 |
15.07 |
18.61 |
|
Adult Immunization Status (AIS-E) - Pneumococcal (66+) |
48.10 |
49.24 |
58.40 |
|
Adult Immunization Status (AIS-E) - Td/Tdap (Total) |
39.72 |
42.17 |
50.60 |
|
Breast Cancer Screening (BCS-E) |
49.83 |
50.12 |
58.93 |
|
Cervical Cancer Screening (CCS) -Total |
50.24 |
52.07 |
61.52 |
|
Childhood Immunization Status (CIS) - Combo 10 |
20.68 |
21.41 |
30.41 |
|
Chlamydia Screening in Women (CHL) Total |
56.11 |
54.25 |
62.81 |
|
Immunizations for Adolescents (IMA) - Combination 2 |
32.02 |
33.33 |
40.39 |
|
Lead Screening in Children (LSC) -Total |
56.69 |
63.50 |
74.62 |
|
Oral Evaluation, Dental Services (OED) - Total |
41.33 |
43.74 |
49.54 |
|
Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) - BMI percentile (Total) |
76.46 |
64.48 |
87.69 |
|
Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) - Counseling for Nutrition (Total) |
67.85 |
63.50 |
77.70 |
|
Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) - Counseling for Physical Activity (Total) |
64.05 |
62.29 |
75.91 |
|
Effectiveness of Care: Respiratory |
|||
|
Asthma Medication Ratio (AMR) -Total |
70.56 |
75.59 |
68.13 |
|
Appropriate Testing for Pharyngitis (CWP) -Total |
85.28 |
87.03 |
87.31 |
|
Pharmacotherapy Management of COPD Exacerbation (PCE) - Bronchodilator |
85.85 |
88.59 |
86.25 |
|
Pharmacotherapy Management of COPD Exacerbation (PCE) -Systemic Corticosteroid |
79.30 |
76.68 |
74.92 |
|
Effectiveness of Care: Cardiovascular |
|||
|
Controlling High Blood Pressure (CBP) |
64.81 |
68.37 |
70.35 |
|
Statin Therapy for Patients With Cardiovascular Disease (SPC) - Received Statin Therapy (Total) |
82.44 |
83.70 |
82.94 |
|
Statin Therapy for Patients With Cardiovascular Disease (SPC) - Statin Adherence 80% (Total) |
72.93 |
72.21 |
75.45 |
|
Effectiveness of Care: Diabetes |
|||
|
Blood Pressure Control for Patients With Diabetes (BPD) |
69.10 |
70.80 |
74.21 |
|
Eye Exam for Patients With Diabetes (EED) |
45.26 |
46.96 |
60.83 |
|
Glycemic Status Assessment for Patients With Diabetes (GSD) - Glycemic Status <8.0% |
53.77 |
51.58 |
63.04 |
|
Glycemic Status Assessment for Patients With Diabetes (GSD) - Glycemic Status >9.0% |
37.47 |
38.20 |
27.98 |
|
Kidney Health Evaluation for Patients With Diabetes (KED) - Total |
35.56 |
38.62 |
46.17 |
|
Statin Therapy for Patients With Diabetes (SPD) - Received Statin Therapy |
67.95 |
69.20 |
69.01 |
|
Statin Therapy for Patients With Diabetes (SPD) - Statin Adherence 80% |
68.34 |
69.49 |
72.29 |
|
Effectiveness of Care: Behavioral Health |
|||
|
Adherence to Antipsychotic Medications for Individuals With Schizophrenia (SAA) |
64.79 |
67.67 |
69.67 |
|
Antidepressant Medication Management (AMM) - Effective Acute Phase Treatment |
62.62 |
64.56 |
66.99 |
|
Antidepressant Medication Management (AMM) - Effective Continuation Phase Treatment |
43.97 |
46.42 |
49.88 |
|
Diabetes Screening for People With Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD) |
82.84 |
84.88 |
84.36 |
|
Follow-Up After Emergency Department Visit for Mental Illness (FUM) - 30 days (Total) |
66.32 |
64.66 |
62.41 |
|
Follow-Up After Emergency Department Visit for Mental Illness (FUM) - 7 days (Total) |
56.60 |
55.01 |
46.71 |
|
Follow-Up After Emergency Department Visit for Substance Use (FUA) - 30 days (Total) |
39.50 |
40.41 |
43.24 |
|
Follow-Up After Emergency Department Visit for Substance Use (FUA) - 7 days (Total) |
25.78 |
27.68 |
30.53 |
|
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) - 30 days (Total) |
53.81 |
60.17 |
62.24 |
|
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) - 7 days (Total) |
36.34 |
42.57 |
40.55 |
|
Follow-Up After Hospitalization for Mental Illness (FUH) - 30 days (Total) |
57.30 |
57.00 |
67.40 |
|
Follow-Up After Hospitalization for Mental Illness (FUH) - 7 days (Total) |
32.71 |
33.12 |
45.08 |
|
Follow-Up Care for Children Prescribed ADHD Medication (ADD-E) - Initiation Phase |
41.88 |
46.22 |
49.56 |
|
Follow-Up Care for Children Prescribed ADHD Medication (ADD-E) - Continuation and Maintenance Phase |
50.24 |
52.78 |
58.69 |
|
Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) - Blood Glucose and Cholesterol Testing (Total) |
31.49 |
32.84 |
41.52 |
|
Effectiveness of Care: Access/Availability of Care |
|||
|
Initiation and Engagement of Substance Use Disorder Treatment (IET) - Initiation of SUD Treatment - Total (Total) |
47.77 |
50.81 |
49.03 |
|
Initiation and Engagement of Substance Use Disorder Treatment (IET) - Engagement of SUD Treatment - Total (Total) |
11.94 |
13.34 |
17.80 |
|
Prenatal and Postpartum Care (PPC) - Timeliness of Prenatal Care |
90.16 |
87.59 |
88.56 |
|
Prenatal and Postpartum Care (PPC) - Postpartum Care |
83.61 |
82.24 |
83.94 |
|
Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) - Total |
54.92 |
56.20 |
82.10 |